PRP for Eyebrow Hypotrichosis and Alopecia Areata
Trial Summary
What is the purpose of this trial?
The purpose of this study is to evaluate the effect of autologous platelet-rich plasma (PRP) in the treatment of mild to moderate eyebrow hypotrichosis.This is a randomized clinical trial to evaluate the effect of autologous platelet rich plasma in subjects with mild to moderate eyebrow hypotrichosis. Approximately 40 subjects will be randomized to receive platelet-rich plasma (PRP) or saline injections. The study is designed as an 9-month study. This study was a pilot study designed to determine feasibility of this procedure.Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment.
Research Team
Murad Alam
Principal Investigator
Northwestern University
Eligibility Criteria
This trial is for adults aged 18-85 in the Chicago area with mild to moderate eyebrow thinning who are healthy and can give informed consent. It's not for those with uncontrolled diseases affecting hair growth, recent use of certain hair growth drugs, significant blood disorders, genetic conditions impacting fibroblasts or collagen, pregnant/breastfeeding individuals, or those unable to follow the study protocol.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive intradermal injections of either autologous PRP or sterile saline to eyebrows, with three treatments performed 1 month apart
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Platelet-rich Plasma
- Saline
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor